BB Biotech AG (XSWX:BION) Beginning Cash Position: CHF98.2 Mil (As of Mar. 2026)


XSWX:BION BB Biotech AG XSWX:BION
34 GF Score
Price CHF50.80
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG Beginning Cash Position?

BB Biotech AG XSWX:BION +2.11% 34 Beginning Cash Position is CHF98.2 Mil as of Mar. 2026. GuruFocus rates XSWX:BION with a GF Score™ of 34/100. The stock has 4 warning signs investors should review.

BB Biotech AG's Beginning Cash Position for the quarter that ended in Mar. 2026 was CHF98.2 Mil.

BB Biotech AG's quarterly Beginning Cash Position increased from Sep. 2025 (CHF2.2 Mil) to Dec. 2025 (CHF81.9 Mil) and increased from Dec. 2025 (CHF81.9 Mil) to Mar. 2026 (CHF98.2 Mil).

BB Biotech AG's annual Beginning Cash Position declined from Dec. 2023 (CHF1.9 Mil) to Dec. 2024 (CHF0.5 Mil) and declined from Dec. 2024 (CHF0.5 Mil) to Dec. 2025 (CHF0.5 Mil).

BB Biotech AG Beginning Cash Position Related Terms

BB Biotech AG Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Beginning Cash Position Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.82 2.83 1.95 0.50 0.46

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 70.18 2.16 81.94 98.22
XSWX:BION
34GF Score
BB Biotech AG XSWX:BION
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of CHF98.2 Mil mean?
BB Biotech AG (XSWX:BION) has a Beginning Cash Position of CHF98.2 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on BB Biotech AG and its competitors.
Is BB Biotech AG's Beginning Cash Position too high?
BB Biotech AG's current Beginning Cash Position is CHF98.2 Mil. Overall, BB Biotech AG has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Beginning Cash Position compare to VRTX and REGN?
BB Biotech AG's Beginning Cash Position of CHF98.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current Beginning Cash Position is CHF98.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Beginning Cash Position of CHF98.2 Mil. The current Beginning Cash Position is CHF98.2 Mil. BB Biotech AG's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Beginning Cash Position is CHF98.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
34GF Score

Get the complete analysis for XSWX:BION

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF50.80
Price